Galapagos

Galapagos is a Belgian biotech company listed on Euronext Brussels and Euronext Amsterdam

Galapagos placed 2,696,831 shares (10% of outstanding shares) in the accelerated bookbuild offering
Participating investors were mainly located in the US, and predominantly included specialist healthcare investors
Kempen acted as Joint Bookrunner, combining supply and demand in order not to put unnecessary pressure on the share price